FGF2 and carcinoma: Increased expression of a number of angiogenic factors has previously been documented in endometrial hyperplasias and carcinomas, including the overexpression of bFGF and VEGF in hyperplasia and adenocarcinoma (Gold et al, 1994; Doldi et al, 1996; Zhang et al, 1998).